 | Up a level |
Heist, Rebecca Suk, Garon, Edward B., Tan, Daniel Shao-Weng, Groen, Harry J. M., Seto, Takashi, Smit, Egbert F., Zou, Mike R., Yang, Yiqun, Li, Ying, Chassot-Agostinho, Andrea and Wolf, Juergen (2021). Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: Results from the GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Wolf, Juergen, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Gilloteau, Isabelle, Le Mouhaer, Sylvie, Cai, Can, Chassot-Agostinho, Andrea, Reynolds, Maria, Odom, Dawn and Heist, Rebecca Suk (2021). Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the phase II GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Wolf, Juergen, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Robeva, Anna, Le Mouhaer, Sylvie, Carbini, Mariana, Chassot-Agostinho, Andrea and Heist, Rebecca Suk (2021). Capmatinib in MET exon 14-mutated, advanced NSCLC: Updated results from the GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755